“…Among the patients with false negative results, 24/111 (21.6%) had false negative results to inaccessible LNs, and these rates were similar to those reported in previous studies [9, 10]. Previous studies have identified several factors associated with false negative results of EBUS/EUS-NA [9, 10, 17], including primary tumor location (central or left lung), abnormal findings of mediastinal LNs on CT and/or PET, inadequacy of the sampling, internal necrosis in the LNs, and rare cancer types. Although we did not perform multivariate analysis to identify the independent patient and tumor characteristics associated with false negative results, young age, female gender, inaccessible stations by EBUS, and larger size of LNs had a trend for higher false negative rates (Tables 1 and 2).…”